GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
As per specifications set at Meda’s 2014 annual general meeting, a nomination committee has been appointed. It consists of:
Bert Åke Eriksson, Committee Chairman, Stena Sessan Rederi AB
Sigieri Diaz Pallavicini, Fidim S.r.l.
Evert Carlsson, Swedbank Robur Funds
Lars Backsell, B&E Participation/Flerie Invest
Martin Svalstedt, Meda’s Chairman of the Board
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 120 countries worldwide and the company is represented by its own organizations in close to 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.
This information was brought to you by Cision http://news.cision.com